Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry

Authors

Nicholas A. Kolaitis, Stanford University
Roham T. Zamanian, Stanford University
Vinicio A. de Jesus Perez, Stanford University
David B. Badesch, University of Colorado Health Sciences Center
Raymond L. Benza, Allegheny General Hospital
Charles D. Burger, Mayo Clinic Florida
Murali M. Chakinala, Washington University
Jean M. Elwing, University of Cincinnati
Jeremy Feldman, Arizona Pulmonary Specialists
Matthew R. Lammi, LSU Health Sciences Center - New OrleansFollow

Document Type

Article

Publication Date

10-15-2020

Publication Title

Annals of the American thoracic society

PubMed ID

33064950

Volume

18(4)

Recommended Citation

Kolaitis, Nicholas A.; Zamanian, Roham T.; de Jesus Perez, Vinicio A.; Badesch, David B.; Benza, Raymond L.; Burger, Charles D.; Chakinala, Murali M.; Elwing, Jean M.; Feldman, Jeremy; and Lammi, Matthew R., "Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry" (2020). School of Medicine Faculty Publications. 1801.
https://digitalscholar.lsuhsc.edu/som_facpubs/1801